Back to Search
Start Over
An In VivoPiggyBacInsertional Mutagenesis Screen Reveals Oncogenic Lesions Cooperating with Myd88 L265P
- Source :
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p525-525, 1p
- Publication Year :
- 2023
-
Abstract
- Diffuse large B cell lymphoma (DLBCL) is the most common Non-Hodgkin lymphoma and originates from transformed germinal center-experienced B cells. Traditionally, DLBCL has been divided into two subtypes, depending on whether the transcriptional profile of the tumor relates to an activated B cell or a germinal center B cell (ABC and GCB DLBCL, Alizadeh et al., 2000). More recent efforts classified DLBCL cases based on their genetic aberrations and identified several clusters with distinct mutational profiles (Chapuy et al., 2018, Schmitz et al., 2018, Wright et al., 2020). The MCD/C5 cluster is characterized by recurrent mutations in MYD88, PRDM1and frequent amplifications of BCL2, amongst others. We recently showed that mice harboring a B cell-specific Myd88 L252Pmutation (orthologous position of the human p.L265P mutation) develop B cell proliferation and occasional transformation into DLBCL (Knittel et al., 2016). Lymphomagenesis is further increased when Myd88 L252Pis combined with BCL2overexpression and a genetically engineered block in plasmacytic differentiation by loss of Prdm1or overexpression of Spib(Flümann et al., 2021).
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 142
- Issue :
- 1, Number 1 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs64699606
- Full Text :
- https://doi.org/10.1182/blood-2023-179915